Dokki Giza, Egypt

Abdel-Maksoud Mohammed



Average Co-Inventor Count = 7.5

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2020-2022

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Abdel-Maksoud Mohammed

Introduction

Abdel-Maksoud Mohammed is a notable inventor based in Dokki Giza, Egypt. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with antitumor effects. With a total of 2 patents to his name, his work is paving the way for advancements in cancer treatment.

Latest Patents

Among his latest patents is the "Imidazooxazole derivative having antitumor effect, and pharmaceutical composition including same." This innovative pharmaceutical composition is designed for preventing and treating tumors. It includes an imidazooxazole derivative compound, a solvate, a stereoisomer, or a pharmaceutically acceptable salt as an active ingredient. The composition is administered to entities that have developed tumors or are at risk of developing them, thereby providing a means to prevent or treat such conditions.

Career Highlights

Abdel-Maksoud Mohammed is affiliated with the Korea Institute of Science and Technology, where he continues to engage in groundbreaking research. His work focuses on the intersection of chemistry and medicine, aiming to create effective treatments for serious health issues.

Collaborations

He collaborates with esteemed colleagues such as Gamal El-din Mahmoud and Hong Seok Choi, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Abdel-Maksoud Mohammed's contributions to pharmaceutical science highlight the importance of innovation in developing effective treatments for cancer. His work not only showcases his expertise but also reflects the collaborative spirit of modern scientific research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…